508
Participants
Start Date
March 27, 2018
Primary Completion Date
December 24, 2020
Study Completion Date
March 24, 2021
Thymosin Alpha 1
In addition to the standard treatment, thymosin therapy will be started after admission: 1.6mg I.H q12h for the first 7 days and 1.6mg I.H, qd for the following 7 days or until discharge.
normal saline
Placebo inject will be given at the same dose as Thymosin in addition to the standard treatment.
Department of SICU, Research Institute of General Surgery Jinling Hospital, Nanjing, Jiangsu, China, Nanjing
Jinling Hospital, Nanjing
The First Affiliated Hospital of Nanchang University
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Zunyi Medical College
OTHER
the Affiliated Nanhua Hospital, University of South China
UNKNOWN
Second Affiliated Hospital of Nantong University
OTHER
Wannan Medical College Yijishan Hospital
OTHER
the 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force
UNKNOWN
Jiangsu Province Hospital of Traditional Chinese Medicine
OTHER
Zhejiang Provincial People's Hospital
OTHER
Luoyang Central Hospital
OTHER
The Affiliated Hospital of Henan University of Science and Technology
UNKNOWN
Clinical Medical College of Yangzhou University
UNKNOWN
The First People's Hospital of Shangqiu
UNKNOWN
Qilu Hospital of Shandong University
OTHER
The First Affiliated Hospital of Anhui Medical University
OTHER
Weiqin Li
OTHER